Vanda Pharmaceuticals
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 203
- Market Cap
- $311.8M
- Introduction
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The ...
Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 25
- Registration Number
- NCT04969211
- Locations
- 🇺🇸
Vanda Investigational Site, Springfield, Missouri, United States
Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 27
- Registration Number
- NCT04849559
- Locations
- 🇺🇸
Vanda Investigational Site, Rochester, Minnesota, United States
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 417
- Registration Number
- NCT04819776
- Locations
- 🇵🇱
Vanda Investigational Site, Tuszyn, Poland
Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 230
- Registration Number
- NCT04800237
- Locations
- 🇺🇸
Vanda Investigational Site, Houston, Texas, United States
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 42
- Registration Number
- NCT04712734
- Locations
- 🇺🇸
Vanda Investigational Site, Marlton, New Jersey, United States
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
- Conditions
- Interventions
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 70
- Registration Number
- NCT04652882
- Locations
- 🇩🇪
Vanda Investigational Site, Schwerin, Germany
Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2022-04-27
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 41
- Registration Number
- NCT04622345
- Locations
- 🇺🇸
Vanda Investigational Site, Andover, Massachusetts, United States
Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis
- Conditions
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Vanda Pharmaceuticals
- Registration Number
- NCT04474990
- Locations
- 🇺🇸
Vanda Investigational Site, Spokane, Washington, United States
WGS Analysis of COVID-19 Positive Patients
- Conditions
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 79
- Registration Number
- NCT04353401
- Locations
- 🇺🇸
Vanda Investigational Site, Cleveland, Ohio, United States
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
- First Posted Date
- 2020-03-31
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 366
- Registration Number
- NCT04327661
- Locations
- 🇺🇸
Gulfcoast Psychiatric Associates, Fort Myers, Florida, United States
🇺🇸Pacific Research Network, LLC, San Diego, California, United States
🇺🇸Santa Monica Clinical Trials, Santa Monica, California, United States